With a global pandemic and a fraught trade war, many are wondering if China’s pharmaceutical monopoly presents a national security threat.
Illustration by Nigel Buchanan
WASHINGTON — The baby had so many pustules ravaging his face he could barely open his right eye, a photograph that left the president, national security adviser and close aides nearly speechless with horror.
A global pandemic had begun in a hospital in Oklahoma City. Doctors soon diagnosed smallpox, a virulent, deadly and disfiguring infection that had disappeared from the planet two decades before. What would the president do?
This was the scenario that a cast of Washington power playe
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
Under President Donald Trump, a strategy built over two administrations to keep China behind in the AI race is adrift. Through interviews with more than two dozen former and current U.S.officials, The Wire China explores the genesis — and unwinding — of Washington’s export controls on computer chips.
The writer and academic discusses why the core differences between the world's two largest economies, the brutality of China's former one-child policy and whether it's right call it a Marxist country.
Navigate China's Business Landscape with Confidence.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
